We use cookies for a better user experience. Read our Privacy Policy

I Agree

Systemic Aspergillosis and Systemic Candidiasis Treatment Market

Systemic Aspergillosis and Systemic Candidiasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market: Introduction

  • Aspergillosis is an infection triggered by a type of mold (fungus). The illnesses caused by aspergillosis infection usually affect the respiratory system. Most strains of this mold are mild; however, a few can cause severe illnesses with weakened immune systems, underlying lung disease or asthma due to inhalation of fungal spores.
  • Systemic candidiasis is a common fungal infection among hospitalized people in high-income countries. Systematic candidiasis treatment generally comprises oral or intravenous (IV) antifungal medications.

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market: Key Trends

  • The global systemic aspergillosis and systemic candidiasis treatment market is driven by increase in incidence of fungal diseases and rise in prevalence of hospital-acquired fungal infection. Candidemia is one of the most common bloodstream infections in the U.S. During 2013–2017, the average incidence of candidemia was nine per 100,000 people in the country.
  • Rise in research & development activities and new drug pipeline are projected to drive the global market during the forecast period. However, undiagnosed cases of systemic aspergillosis and systemic candidiasis are anticipated to restrain the global market.

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Segmentation

  • In terms of type, the global systemic aspergillosis and systemic candidiasis treatment market can be classified into voriconazole, liposomal amphotericin B, systemic oral azoles, topical antifungal agents, and others. The systemic oral azoles segment accounted for major share of the global market in 2020.
  • Based on application, the global systemic aspergillosis and systemic candidiasis treatment market can be divided into chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), gastrointestinal candidiasis, genitourinary tract candidiasis, and others. The allergic bronchopulmonary aspergillosis (ABPA) segment held significant share of the global market in 2020.

North America accounted for Major Share of Global Market

  • North America is projected to dominate the global market during the forecast period due to increase in awareness about fungal and infectious diseases. Additionally, rise in prevalence of immunological diseases and increase in health care expenditure are anticipated to drive the systemic aspergillosis and systemic candidiasis treatment market in North America during the forecast period.
  • The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in prevalence of fungal diseases and increase in hospital-acquired fungal infections

Key Players Operating in Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market

Major players operating in the global systemic aspergillosis and systemic candidiasis treatment market are:

  • Basilea Pharmaceutica Ltd.
  • Astellas Pharma, Inc.
  • Grupo Ferrer International, S.A.
  • Pacgen Life Science Corporation
  • NovaDigm Therapeutics, Inc.
  • Cidara Therapeutics, Inc.
  • Amplyx Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Novartis AG
  • Sanofi
  • Merck & Co., Inc.
  • Bayer AG
  • GlaxoSmithKline plc.
  • Abbott
  • Cipla, Inc.
  • Ferrer International
  • Other prominent players

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market: Research Scope

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, by Type

  • Voriconazole
  • Liposomal Amphotericin B
  • Systemic Oral Azoles
  • Topical Antifungal Agents
  • Others

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, by Application

  • Chronic Pulmonary Aspergillosis (CPA)
  • Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Gastrointestinal Candidiasis
  • Genitourinary Tract Candidiasis
  • Others

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Systemic Aspergillosis and Systemic Candidiasis Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

805

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved